Special Issue "Diagnosis and Management of HIV Infection"
Deadline for manuscript submissions: closed (20 January 2022) | Viewed by 9832
Despite the availability of effective combination antiretroviral therapy (ART), HIV infection is still a major global health threat. The UNAIDS 90–90–90 target (which means diagnosing 90% of all people living with HIV (PLWH), providing ART to 90% of those diagnosed, and achieving viral suppression for 90% of those on ART), advocated to end the AIDS epidemic, is unlikely to be met soon in many areas. Crucial factors that need to be addressed to reach this goal are scaling up HIV testing, improving access to ART, optimizing ART based on resistance monitoring, reducing loss to follow-up for those on ART, and optimally diagnosing and managing comorbidities that could impact ART adherence and final prognosis. Moreover, patients achieving viral suppression and adequate immune reconstitution on ART represent a challenging population. Accelerated aging and an increased prevalence of non-AIDS-related comorbidities (e.g., cancers, neurocognitive, cardiovascular, hepatic, renal and bone diseases) make PLWH a difficult-to-treat population. Both HIV-specific expertise and internal medicine/primary care knowledge are required to optimally manage PLWH. On this basis, further research is needed to better understand the complex aspects of HIV infection and to optimize strategies for its diagnosis and management.
The aim of this Special Issue is to publish high-quality research on any aspect of diagnosis and management of HIV infection and its related comorbidities. Original research articles and reviews summarizing the state of ART of HIV medicine are welcome.
Dr. Massimiliano Fabbiani
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- HIV testing
- HIV viral load
- genotypic resistance test
- phenotypic resistance test
- antiretroviral therapy
- opportunistic infections
- non-AIDS-related comorbidities